High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment

被引:58
|
作者
Di Veroli, Giovanni Y. [1 ]
Davies, Mark R.
Zhang, Henggui
Abi-Gerges, Najah
Boyett, Mark R. [1 ]
机构
[1] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9NT, Lancs, England
关键词
computational modeling; human ether-a-go-go-related gene ion channel; drug-binding kinetics; QT prolongation; Torsades de Pointes arrhythmia; QT INTERVAL PROLONGATION; POTASSIUM CHANNEL; I-KR; VENTRICULAR ARRHYTHMIA; PROARRHYTHMIC RISK; ION CHANNELS; REPOLARIZATION; ELECTROPHYSIOLOGY; CISAPRIDE; BLOCK;
D O I
10.1152/ajpheart.00511.2012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Di Veroli GY, Davies MR, Zhang H, Abi-Gerges N, Boyett MR. High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment. Am J Physiol Heart Circ Physiol 304: H104-H117, 2013. First published October 26, 2012; doi:10.1152/ajpheart.00511.2012.-The use of computational models to predict drug-induced changes in the action potential (AP) is a promising approach to reduce drug safety attrition but requires a better representation of more complex drug-target interactions to improve the quantitative prediction. The blockade of the human ether-a-go-go-related gene (HERG) channel is a major concern for QT prolongation and Torsade de Pointes risk. We aim to develop quantitative in-silico AP predictions based on a new electrophysiological protocol (suitable for high-throughput HERG screening) and mathematical modeling of ionic currents. Electrophysiological recordings using the IonWorks device were made from HERG channels stably expressed in Chinese hamster ovary cells. A new protocol that delineates inhibition over time was applied to assess dofetilide, cisapride, and almokalant effects. Dynamic effects displayed distinct profiles for these drugs compared with concentration-effects curves. Binding kinetics to specific states were identified using a new HERG Markov model. The model was then modified to represent the canine rapid delayed rectifier K+ current at 37 degrees C and carry out AP predictions. Predictions were compared with a simpler model based on conductance reduction and were found to be much closer to experimental data. Improved sensitivity to concentration and pacing frequency variables was obtained when including binding kinetics. Our new electrophysiological protocol is suitable for high-throughput screening and is able to distinguish drug-binding kinetics. The association of this protocol with our modeling approach indicates that quantitative predictions of AP modulation can be obtained, which is a significant improvement compared with traditional conductance reduction methods.
引用
收藏
页码:H104 / H117
页数:14
相关论文
共 50 条
  • [31] High-Throughput Drug Screening of ECM Deposition Inhibitors for Antifibrotic Drug Discovery
    Gerckens, Michael
    Alsafadi, Hani
    Wagner, Darcy
    Heinzelmann, Katharina
    Schorpp, Kenji
    Hadian, Kamyar
    Lindner, Michael
    Behr, Juergen
    Koenigshoff, Melanie
    Eickelberg, Oliver
    Yildirim, Ali Oender
    Burgstaller, Gerald
    PNEUMOLOGIE, 2019, 73 (02):
  • [32] Estimating hERG drug binding using temperature-controlled high-throughput automated patch-clamp
    Lindqvist, Anders
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 99
  • [33] Integrated high-throughput drug screening microfluidic system for comprehensive ocular toxicity assessment
    Cho, Kyongjin
    Lee, Jinho
    Kim, Jeongyun
    TOXICOLOGY IN VITRO, 2024, 98
  • [34] High-Throughput Screening Platform for Anticancer Therapeutic Drug Cytotoxicity
    Sekhon, Bhagwant Kaur
    Roubin, Rebecca Heidi
    Tan, Aaron
    Chan, Wing Keung
    Sze, Daniel Man-Yuen
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2008, 6 (05) : 711 - 721
  • [35] Engineering a Brain Cancer Chip for High-throughput Drug Screening
    Fan, Yantao
    Duong Thanh Nguyen
    Akay, Yasemin
    Xu, Feng
    Akay, Metin
    SCIENTIFIC REPORTS, 2016, 6
  • [36] High-Throughput Native Mass Spectrometry Screening in Drug Discovery
    Gavriilidou, Agni F. M.
    Sokratous, Kleitos
    Yen, Hsin-Yung
    De Colibus, Luigi
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [37] High-Throughput Screening of Stapled Helical Peptides in Drug Discovery
    Zhang, Yiwei
    Guo, Jiabei
    Cheng, Jiongjia
    Zhang, Zhenghua
    Kang, Fenghua
    Wu, Xiaoxing
    Chu, Qian
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (01) : 95 - 106
  • [38] Toward high-throughput drug screening using mass spectrometry
    Maurer, HH
    Peters, FT
    THERAPEUTIC DRUG MONITORING, 2005, 27 (06) : 686 - 688
  • [39] The impact of microfluidics in high-throughput drug-screening applications
    De Stefano, Paola
    Bianchi, Elena
    Dubini, Gabriele
    BIOMICROFLUIDICS, 2022, 16 (03)
  • [40] Distributed Virtual High-Throughput Screening: A boon for drug discovery
    Begemann, John H.
    Scientific Computing and Instrumentation, 2004, 21 (03): : 18 - 24